|
1
|
Shampo MA, Kyle RA and Steensma DP: Alois
Alzheimer-Alzheimer disease. Mayo Clin Proc. 88:pp. e1552013;
View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Alzheimer's Association. 2017 Alzheimer's
disease facts and figures. Alzheimers Dement. 13:325–373. 2017.
View Article : Google Scholar
|
|
3
|
Nithianantharajah J and Hannan AJ: The
neurobiology of brain and cognitive reserve: Mental and physical
activity as modulators of brain disorders. Prog Neurobiol.
89:369–382. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Arbor SC, LaFontaine M and Cumbay M:
Amyloid-beta Alzheimer targets-protein processing, lipid rafts, and
amyloid-beta pores. Yale J Biol Med. 89:5–21. 2016.PubMed/NCBI
|
|
5
|
Su F, Bai F and Zhang Z: Inflammatory
cytokines and Alzheimer's disease: A review from the perspective of
genetic polymorphisms. Neurosci Bull. 32:469–480. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Lénárt N, Brough D and Dénes Á:
Inflammasomes link vascular disease with neuroinflammation and
brain disorders. J Cereb Blood Flow Metab. 36:1668–1685. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Hall JR, Wiechmann AR, Johnson LA, Edwards
M, Barber RC, Cunningham R, Singh M and O'Bryant SE: Total
cholesterol and neuropsychiatric symptoms in Alzheimer's disease:
The impact of total cholesterol level and gender. Dement Geriatr
Cogn Disord. 38:300–309. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Rea R, Carotenuto A, Fasanaro AM, Traini E
and Amenta F: Apathy in Alzheimer's disease: Any effective
treatment? Scientific World Journal 2014. 4213852014.
|
|
9
|
Zheng C, Zhou XW and Wang JZ: The dual
roles of cytokines in Alzheimer's disease: Update on interleukins,
TNF-α, TGF-β and IFN-γ. Transl Neurodegener. 5:72016. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Tompkins LM and Wallace AD: Mechanisms of
cytochrome P450 induction. J Biochem Mol Toxicol. 21:176–181. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Souslova T, Marple TC, Spiekerman AM and
Mohammad AA: Personalized medicine in Alzheimer's disease and
depression. Contemp Clin Trials. 36:616–623. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Lu J, Wan L, Zhong Y, Yu Q, Han Y, Chen P,
Wang B, Li W, Miao Y and Guo C: Stereoselective metabolism of
donepezil and steady-state plasma concentrations of S-donepezil
based on CYP2D6 polymorphisms in the therapeutic responses of Han
Chinese patients with Alzheimer's disease. J Pharmacol Sci.
129:188–195. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Yan H, Kong Y, He B, Huang M, Li J, Zheng
J, Liang L, Bi J, Zhao S and Shi L: CYP2J2 rs890293 polymorphism is
associated with susceptibility to Alzheimer's disease in the
Chinese Han population. Neurosci Lett. 593:56–60. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Mast N, Li Y, Linger M, Clark M, Wiseman J
and Pikuleva IA: Pharmacologic stimulation of cytochrome P450 46A1
and cerebral cholesterol turnover in mice. J Biol Chem.
289:3529–3538. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Bolivar VJ, Manley K and Messer A:
Exploratory activity and fear conditioning abnormalities develop
early in R6/2 Huntington's disease transgenic mice. Behav Neurosci.
117:1233–1242. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Mohri I, Kadoyama K, Kanekiyo T, Sato Y,
Kagitani-Shimono K, Saito Y, Suzuki K, Kudo T, Takeda M, Urade Y,
et al: Hematopoietic prostaglandin D synthase and DP1 receptor are
selectively upregulated in microglia and astrocytes within senile
plaques from human patients and in a mouse model of Alzheimer
disease. J Neuropathol Exp Neurol. 66:469–480. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Nathalie P and Jean-Noël O: Processing of
amyloid precursor protein and amyloid peptide neurotoxicity. Curr
Alzheimer Res. 5:92–99. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Iqbal K and Grundke-Iqbal I: Alzheimer
neurofibrillary degeneration: Significance, etiopathogenesis,
therapeutics and prevention. J Cell Mol Med. 12:38–55. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Kashimata M, Sayeed S, Ka A, Onetti-Muda
A, Sakagami H, Faraggiana T and Gresik EW: The ERK-1/2 signaling
pathway is involved in the stimulation of branching morphogenesis
of fetal mouse submandibular glands by EGF. Dev Biol. 220:183–196.
2000. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Laursen T, Jensen K and Møller BL:
Conformational changes of the NADPH-dependent cytochrome P450
reductase in the course of electron transfer to cytochromes P450.
Biochim Biophys Acta. 1814:132–138. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Yao Y, Liu S, Wang Y, Yuan W, Ding X,
Cheng T, Shen Q and Gu J: Suppression of cytochrome P450 reductase
expression promotes astrocytosis in subventricular zone of adult
mice. Neurosci Lett. 548:84–89. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Webster SJ, Bachstetter AD, Nelson PT,
Schmitt FA and Van Eldik LJ: Using mice to model Alzheimer's
dementia: An overview of the clinical disease and the preclinical
behavioral changes in 10 mouse models. Front Genet. 5:882014.
View Article : Google Scholar : PubMed/NCBI
|
